Hormonal Therapy Resistance and Breast Cancer: Involvement of Adipocytes and Leptin

被引:21
|
作者
Delort, Laetitia [1 ]
Bougaret, Lauriane [1 ]
Cholet, Juliette [1 ]
Vermerie, Marion [1 ]
Billard, Hermine [1 ]
Decombat, Caroline [1 ]
Bourgne, Celine [2 ]
Berger, Marc [2 ]
Dumontet, Charles [3 ]
Caldefie-Chezet, Florence [1 ]
机构
[1] Univ Clermont Auvergne, CRNH Auvergne, INRA, UNH, F-63000 Clermont Ferrand, France
[2] CHU Estaing, Serv Hematol Biol, F-63000 Clermont Ferrand, France
[3] Univ Lyon 1, INSERM U1052, CNRS 5286, Canc Res Ctr Lyon, F-69008 Lyon, France
关键词
breast cancer; adipose secretome; leptin; hormonal therapy resistance; cancer stem cells; ADIPOSE-TISSUE; ENDOCRINE THERAPY; STEM-CELLS; IDENTIFICATION; INTERLEUKIN-6; OBESITY; STAT3;
D O I
10.3390/nu11122839
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Obesity, a recognized risk factor for breast cancer in postmenopausal women, is associated with higher mortality rates regardless of menopausal status, which could in part be explained by therapeutic escape. Indeed, adipose microenvironment has been described to influence the efficiency of chemo- and hormonal therapies. Residual cancer stem cells could also have a key role in this process. To understand the mechanisms involved in the reduced efficacy of hormonal therapy on breast cancer cells in the presence of adipose secretome, human adipose stem cells (hMAD cell line) differentiated into mature adipocytes were co-cultured with mammary breast cancer cells and treated with hormonal therapies (tamoxifen, fulvestrant). Proliferation and apoptosis were measured (fluorescence test, impedancemetry, cytometry) and the gene expression profile was evaluated. Cancer stem cells were isolated from mammospheres made from MCF-7. The impact of chemo- and hormonal therapies and leptin was evaluated in this population. hMAD-differentiated mature adipocytes and their secretions were able to increase mammary cancer cell proliferation and to suppress the antiproliferative effect of tamoxifen, confirming previous data and validating our model. Apoptosis and cell cycle did not seem to be involved in this process. The evaluation of gene expression profiles suggested that STAT3 could be a possible target. On the contrary, leptin did not seem to be involved. The study of isolated cancer stem cells revealed that their proliferation was stimulated in the presence of anticancer therapies (tamoxifen, fulvestrant, doxorubicine) and leptin. Our study confirmed the role of adipocytes and their secretome, but above all, the role of communication between adipose and cancer cells in interfering with the efficiency of hormonal therapy. Among the pathophysiological mechanisms involved, leptin does not seem to interfere with the estrogenic pathway but seems to promote the proliferation of cancer stem cells.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Neoadjuvant hormonal therapy for endocrine sensitive breast cancer: A systematic review
    Charehbili, A.
    Fontein, D. B. Y.
    Kroep, J. R.
    Liefers, G. J.
    Mieog, J. S. D.
    Nortier, J. W. R.
    van de Velde, C. J. H.
    CANCER TREATMENT REVIEWS, 2014, 40 (01) : 86 - 92
  • [42] Hormonal Resistance in Breast Cancer: Evolving Treatment Strategies
    Khasraw, Mustafa
    Harvey, Sandra L.
    Bell, Richard
    CURRENT BREAST CANCER REPORTS, 2012, 4 (01) : 66 - 74
  • [43] Leptin and breast cancer: an overview
    Mehmet Artac
    Kadri Altundag
    Medical Oncology, 2012, 29 : 1510 - 1514
  • [44] Hormonal Resistance in Breast Cancer: Evolving Treatment Strategies
    Mustafa Khasraw
    Sandra L. Harvey
    Richard Bell
    Current Breast Cancer Reports, 2012, 4 (1) : 66 - 74
  • [45] Hormonal treatment in breast cancer
    Delozier, T.
    JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION, 2010, 39 (08): : F71 - F78
  • [46] Involvement of Akt and mTOR in chemotherapeutic and hormonal-based drug resistance and response to radiation in breast cancer cells
    Steelman, Linda S.
    Navolanic, Patrick
    Chappell, William H.
    Abrams, Stephen L.
    Wong, Ellis W. T.
    Martelli, Alberto M.
    Cocco, Lucio
    Stivala, Franca
    Libra, Massimo
    Nicoletti, Ferdinando
    Drobot, Lyudmyla B.
    Franklin, Richard A.
    McCubrey, James A.
    CELL CYCLE, 2011, 10 (17) : 3003 - 3015
  • [47] Circulating levels of leptin, adiposity and breast cancer risk
    Wu, M-H
    Chou, Y-C
    Chou, W-Y
    Hsu, G-C
    Chu, C-H
    Yu, C-P
    Yu, J-C
    Sun, C-A
    BRITISH JOURNAL OF CANCER, 2009, 100 (04) : 578 - 582
  • [48] Adipocytes in Breast Cancer, the Thick and the Thin
    Rybinska, Ilona
    Agresti, Roberto
    Trapani, Anna
    Tagliabue, Elda
    Triulzi, Tiziana
    CELLS, 2020, 9 (03)
  • [49] Hormonal therapy after endometrial and breast cancer treatment
    Bidzinski, Mariusz
    Danska-Bidzinska, Anna
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2005, 4 (04): : 73 - 76
  • [50] Breast cancer in menopausal women with hormonal replacement therapy
    Rosales, E
    Sordia, L
    Vazquez, J
    Iglesias, JL
    Morales, A
    Castañeda, M
    Vidal, O
    Saldivar, D
    Merino, M
    García, M
    RESEARCH PAPERS IN FERTILITY AND REPRODUCTIVE MEDICINE, 2004, 1271 : 414 - 416